Data Streaming

摘要

A new tool for optimising cell feed strategy and upstream process development has been unveiled. Nuclear magnetic resonance technology is rapidly developing Quality by Design data and has been successfully applied in clinical studies. Market growth for biologies and biosimilar products is being driven by the success of monoclonal antibodies and the increasing use of other recombinant therapeutic proteins and vaccines.The market share of biologies is predicted to continue rising over the next five years,as big pharmaceutical companies increase the number of vaccines and protein therapeutics in their portfolios. This has resulted in an increasing need for better and faster analytical methods amenable to the monitoring of the whole cycle of bioprocess development and manufacturing.